Twin sisters Linda Thomas and Karen Rodman are back home after a kidney transplant from one twin to the other at Cedars-Sinai ...
Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...
Janssen Research & Development was granted FDA orphan designation for a treatment of multiple myeloma, according to a post to the agency’s ...
Many of you may remember from this column that I have multiple myeloma, or cancer of the bone marrow. In January, I will be headed to UVA hospital for a ...
Samer A. Al’Hadidi, MD, discusses factors influencing early use of chimeric antigen receptor T-cell therapy in patients with ...
Researchers sought to determine whether cilta-cel would have similar results in a real-world RRMM population as in a clinical trial population.
Zacks.com on MSN2d
FDA Accepts GSK's BLA for Blenrep Combos in Multiple MyelomaGSK plc GSK announced that the FDA accepted its biologics license application (BLA) seeking approval for the Blenrep ...
Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...
The acquisition announcement came alongside the reveal of a Phase III failure for Roche’s TIGIT asset tiragolumab, which when ...
Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, ...
A quadruplet regimen is now the preferred first-line treatment for multiple myeloma in both transplant-eligible and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback